News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
Search Query
Submit Search
BioSpace News Archive
Browse BioSpace’s published news and press releases by year, month, and day.
138 Results
Year
2005 (24679)
2006 (34770)
2007 (39687)
2008 (39410)
2009 (42118)
2010 (39616)
2011 (38383)
2012 (38416)
2013 (36268)
2014 (39672)
2015 (44432)
2016 (38329)
2017 (37188)
2018 (39119)
2019 (51334)
2020 (57663)
2021 (58720)
2022 (53927)
2023 (42564)
2024 (37441)
2025 (33090)
2026 (21926)
Month
January (3218)
February (3391)
March (3462)
April (3660)
May (4506)
June (2887)
July (2191)
August (2499)
September (2720)
October (3233)
November (3383)
December (2291)
Day
1 (190)
2 (123)
5 (141)
6 (141)
7 (169)
8 (187)
9 (100)
12 (133)
13 (138)
14 (122)
15 (129)
16 (48)
19 (83)
20 (66)
21 (95)
22 (49)
23 (90)
24 (1)
26 (99)
27 (109)
28 (135)
29 (105)
30 (46)
Year
2005
2006
2007
2008
2009
2010
2011
2012
2013
2014
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
2026
Month
January
February
March
April
May
June
July
August
September
October
November
December
Day
1
2
5
6
7
8
9
12
13
14
15
16
19
20
21
22
23
24
26
27
28
29
30
Immunology and inflammation
Galderma’s IL-31 Injection Wins FDA Approval for Skin Disorder Prurigo Nodularis
The Swiss company’s monoclonal antibody Nemluvio is also undergoing regulatory review for atopic dermatitis, which is a potentially larger market for the first-in-class IL-31 blocker.
August 13, 2024
·
2 min read
·
Tristan Manalac
Press Releases
Marvel Announces Its Collaboration with FRAXA to Test MB204 In Pre-Clinical Models of Fragile X Syndrome
August 13, 2024
·
5 min read
Business
AIM ImmunoTech to Discuss Second Quarter 2024 Financial Results on August 16, 2024, and Host Conference Call and Webcast
August 13, 2024
·
1 min read
Business
Adial Pharmaceuticals Signs Agreement with Boudicca Dx to Advance Regulatory Strategy for Companion Diagnostic Genetic Test for AD04
August 13, 2024
·
5 min read
Press Releases
Xcelerate, Inc. Releases Shareholder Update
August 13, 2024
·
3 min read
Press Releases
Hop On A Cure Announces Grant for Duke University ALS Clinic Study on Efficacy of BL-001 in People With ALS
August 13, 2024
·
2 min read
Press Releases
Ultima Genomics adds tenured leadership to drive operational excellence and commercial adoption
August 13, 2024
·
3 min read
Press Releases
Nicklaus Children’s Hospital is the Only Children’s Hospital in Florida Now Offering Intestinal Ultrasounds to Patients with Inflammatory Bowel Disease
August 13, 2024
·
2 min read
Press Releases
Telo Genomics Receives CLIA Certification
August 13, 2024
·
4 min read
Press Releases
Therma Bright Welcomes Medical & Pharmaceutical Veteran Michael Raimondo to Its Advisory Board
August 13, 2024
·
4 min read
Previous
10 of 14
Next
